10x Genomics Inc. - notizie pubblicate 220 - letture 7.997
10X GENOMICS INC.
10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024
Pleasanton, calif., july 12, 2024/prnewswire/ -- 10x genomics, inc. (nasdaq: txg), a leader in single cell and spatial biology, today announced that it will report financial result ...
10X GENOMICS INC.
Management Change/Compensation Form 8 K
Item 5.02 departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers. on july 10, 2024, upon ...
10X GENOMICS INC.
Initial Statement of Beneficial Ownership - Form 3
Ownership submission form 3 united states securities and exchange commission washington, d.c. 20549initial statement of beneficial ownership of securities filed pursuant to section ...
10X GENOMICS INC.
Management Change/Compensation Form 8 K
Item 5.02 departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers. on june 18, 2024, upon ...
10X GENOMICS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
10X GENOMICS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
10X GENOMICS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
10X GENOMICS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
10X GENOMICS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
10X GENOMICS INC.
Submission of Matters to a Vote of Security Holders Form 8 K
Item 5.07 submission of matters to a vote of security holders the annual meeting of stockholders of 10x genomics, inc. (the "company") was held on june 11, 2024, via live ...
10X GENOMICS INC.
Additional Proxy Soliciting Materials - Form DEFA14A
Document united states securities and exchange commission washington, d.c. 20549 ______________________ schedule 14a proxy statement pursuant to section 14(a) of the securities exc ...
10X GENOMICS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
10X GENOMICS INC.
10x Genomics Launches 5,000-Plex Gene Panel for Xenium
New xenium prime 5k pan-tissue and pathways panel increases plex by an order of magnitude and delivers industry-leading speed and throughput pleasanton, calif., may 29, 2024/prnews ...
10X GENOMICS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
10X GENOMICS INC.
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
Per i consulenti finanziari
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti